Jinping Lai

发表

Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathways

J. Sarkaria, L. Roberts, S. Kaufmann, 2006, Molecular Cancer Therapeutics.

Loss of HSulf-1 Up-regulates Heparin-binding Growth Factor Signaling in Cancer*

David I. Smith, J. Chien, L. Roberts, 2003, Journal of Biological Chemistry.

SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma.

Chunrong Yu, T. Han, C. Moser, 2006, Gastroenterology.

Decreased Expression of Sulfatase 2 in the Brains of Alzheimer’s Disease Patients: Implications for Regulation of Neuronal Cell Signaling

R. Petersen, R. Roberts, C. Moser, 2017, Journal of Alzheimer's disease reports.

Sulfatase-2 Regulates Liver Fibrosis through the TGF-β Signaling Pathway

C. Moser, L. Roberts, I. Nakamura, 2021, Cancers.

Sulfatase 2 up‐regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma

S. Thorgeirsson, T. Han, Ju-Seog Lee, 2008, Hepatology.

AWARD NUMBER: W81XWH-04-1-0085 TITLE: Functional Characterization of a Novel Pro-Apoptotic Transcription Regulatory Protein in Ovarian Cancer

L. Hartmann, G. Prendergast, J. Chien, 2007 .

A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformation

G. Prendergast, J. Chien, L. Roberts, 2008, Oncogene.

Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitors

S. Sanderson, C. Moser, L. Roberts, 2010, Liver international : official journal of the International Association for the Study of the Liver.

Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets.

L. Roberts, D. Sandhu, J. Lai, 2008, Future oncology.

Heparin-Degrading Sulfatases in Hepatocellular Carcinoma: Potential roles in Pathogenesis and Identification of Therapeutic Targets

L. Roberts, J. Thompson, D. Sandhu, 2011 .

hSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling.

David I. Smith, J. Cunningham, J. Chien, 2004, Gastroenterology.

Abrogation of MAPK and Akt Signaling by AEE788 Synergistically Potentiates Histone Deacetylase Inhibitor-Induced Apoptosis through Reactive Oxygen Species Generation

P. Atadja, L. Roberts, A. Adjei, 2007, Clinical Cancer Research.

Parkin gene alterations in hepatocellular carcinoma

Fang Wang, Christine Klein, Norman Kock, 2004, Genes, chromosomes & cancer.

Restoration of Epigenetically Silenced Sulfatase 1 Expression by 5-Aza-2′-Deoxycytidine Sensitizes Hepatocellular Carcinoma Cells to Chemotherapy-Induced Apoptosis

C. Moser, L. Roberts, N. Tsuchiya, 2015, Medical Epigenetics.

Sulfatase 1 and sulfatase 2 in hepatocellular carcinoma: Associated signaling pathways, tumor phenotypes, and survival

S. Thorgeirsson, Ju-Seog Lee, I. Chu, 2011, Genes, chromosomes & cancer.

Additive effect of apicidin and doxorubicin in sulfatase 1 expressing hepatocellular carcinoma in vitro and in vivo.

S. Sanderson, C. Moser, L. Roberts, 2009, Journal of hepatology.

HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma

David I. Smith, J. Chien, L. Roberts, 2004, Oncogene.

The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX.

S. Thibodeau, J. Cunningham, C. Moser, 2008, Journal of hepatology.

The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3–dependent Wnt activation

Sherine F. Elsawa, T. Han, S. Sanderson, 2010, Hepatology.

The Tumor Suppressor Function of Human Sulfatase 1 (SULF1) in Carcinogenesis

L. Roberts, D. Sandhu, A. Shire, 2008, Journal of gastrointestinal cancer.